Skip to main content
Top
Published in: Diabetologia 11/2006

01-11-2006 | Article

Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes

Authors: S. Bidel, G. Hu, Q. Qiao, P. Jousilahti, R. Antikainen, J. Tuomilehto

Published in: Diabetologia | Issue 11/2006

Login to get access

Abstract

Aims/hypothesis

Higher habitual coffee drinking has been associated with a lower risk of developing type 2 diabetes. The relation between coffee consumption and risk of cardiovascular disease (CVD) has been examined in many studies, but the issue remains controversial. This study was designed to assess the association between coffee consumption and CVD mortality among patients with type 2 diabetes.

Methods

We prospectively followed 3,837 randomly ascertained Finnish patients with type 2 diabetes aged 25 to 74 years. Coffee consumption and other study parameters were determined at baseline. The International Classification of Diseases was used to identify CHD, CVD and stroke cases using computerised record linkage to the national Death Registry. The associations between coffee consumption at baseline and risk of total, CVD, CHD, and stroke mortality were analysed by using Cox proportional hazards models.

Results

During the average follow-up of 20.8 years, 1,471 deaths were recorded, of which 909 were coded as CVD, 598 as CHD and 210 as stroke. The respective multivariate-adjusted hazard ratios in participants who drank 0–2, 3–4, 5–6, and ≥7 cups of coffee daily were 1.00, 0.77, 0.68 and 0.70 for total mortality (P<0.001 for trend), 1.00, 0.79, 0.70 and 0.71 for CVD mortality (P=0.006 for trend), 1.00, 0.78, 0.70 and 0.63 for CHD mortality (p=0.01 for trend), and 1.00, 0.77, 0.64 and 0.90 for stroke mortality (p=0.12 for trend).

Conclusions/interpretation

In this large prospective study we found that in type 2 diabetic patients coffee drinking is associated with reduced total, CVD and CHD mortality.
Literature
1.
go back to reference Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall study. Br Med J 287:867–870CrossRef Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall study. Br Med J 287:867–870CrossRef
2.
3.
go back to reference Stamler J, Vaccaro O, Neaton J, Wentworth D for the Multiple Risk Factor Intervention Trial Research Group (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434–444PubMed Stamler J, Vaccaro O, Neaton J, Wentworth D for the Multiple Risk Factor Intervention Trial Research Group (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434–444PubMed
4.
go back to reference Abel ED (2005) Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 5:219–226PubMedCrossRef Abel ED (2005) Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 5:219–226PubMedCrossRef
5.
go back to reference Van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477–1478PubMedCrossRef Van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477–1478PubMedCrossRef
6.
go back to reference Salazar-Martinez E, Willett WC, Ascherio A et al (2004) Coffee consumption and risk of Type 2 diabetes in men and women. Ann Intern Med 140:1–8PubMed Salazar-Martinez E, Willett WC, Ascherio A et al (2004) Coffee consumption and risk of Type 2 diabetes in men and women. Ann Intern Med 140:1–8PubMed
7.
go back to reference Tuomilehto J, Hu Gang, Bidel S, Lindström J, Jousilahti P (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291:1213–1219PubMedCrossRef Tuomilehto J, Hu Gang, Bidel S, Lindström J, Jousilahti P (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291:1213–1219PubMedCrossRef
8.
go back to reference Van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294:97–104PubMedCrossRef Van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294:97–104PubMedCrossRef
9.
10.
go back to reference Kawachi I, Colditz GA, Stone CB (1994) Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 72:269–275PubMed Kawachi I, Colditz GA, Stone CB (1994) Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 72:269–275PubMed
11.
go back to reference Greenland S (1993) A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4:366–374PubMedCrossRef Greenland S (1993) A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4:366–374PubMedCrossRef
12.
go back to reference Willett WC, Stampfer MJ, Manson JE et al (1996) Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA 275:458–462PubMedCrossRef Willett WC, Stampfer MJ, Manson JE et al (1996) Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA 275:458–462PubMedCrossRef
13.
go back to reference Woodward M, Tunstall-Pedoe H (1999) Coffee and tea consumption in the Scottish heart health study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 53:481–487PubMedCrossRef Woodward M, Tunstall-Pedoe H (1999) Coffee and tea consumption in the Scottish heart health study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 53:481–487PubMedCrossRef
14.
go back to reference Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J (2000) Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 160:3393–3400PubMedCrossRef Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J (2000) Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 160:3393–3400PubMedCrossRef
15.
go back to reference Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C (2003) The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case–control study. J Nutr 133:3228–3232PubMed Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C (2003) The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case–control study. J Nutr 133:3228–3232PubMed
16.
go back to reference Happonen P, Voutilainen S, Salonen JT (2004) Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J Nutr 134:2381–2386PubMed Happonen P, Voutilainen S, Salonen JT (2004) Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J Nutr 134:2381–2386PubMed
17.
go back to reference Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H (2006) Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295:1135–1141PubMedCrossRef Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H (2006) Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295:1135–1141PubMedCrossRef
18.
go back to reference Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P (2000) Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol 29:49–56PubMedCrossRef Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P (2000) Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol 29:49–56PubMedCrossRef
19.
go back to reference WHO MONICA Project Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41:105–114CrossRef WHO MONICA Project Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41:105–114CrossRef
20.
go back to reference World Health Organization Study Group on Diabetes Mellitus (1985) Diabetes Mellitus: Report of a WHO Study Group. WHO Technical Report Series No 727 World Health Organization Study Group on Diabetes Mellitus (1985) Diabetes Mellitus: Report of a WHO Study Group. WHO Technical Report Series No 727
21.
go back to reference World Health Organization Consultation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva World Health Organization Consultation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva
22.
go back to reference Hu G, Eriksson J, Barengo NC et al (2004) Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 110:666–673PubMedCrossRef Hu G, Eriksson J, Barengo NC et al (2004) Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 110:666–673PubMedCrossRef
23.
go back to reference Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J (2005) Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 28:799–805PubMed Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J (2005) Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 28:799–805PubMed
24.
go back to reference Cox DR (1972) Regression models and life tables (with discussion). JR Stat Soc B 34:187–220 Cox DR (1972) Regression models and life tables (with discussion). JR Stat Soc B 34:187–220
25.
go back to reference DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRef DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405CrossRef
26.
go back to reference Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J (2005) Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 48:856–861PubMedCrossRef Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J (2005) Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 48:856–861PubMedCrossRef
27.
go back to reference Wei M, Gaskill SP, Haffner SM, Stern MP (1998) Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21:1167–1172PubMed Wei M, Gaskill SP, Haffner SM, Stern MP (1998) Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21:1167–1172PubMed
28.
go back to reference Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63–68PubMed Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63–68PubMed
29.
go back to reference Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R (2006) Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr 83:1039–1046PubMed Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R (2006) Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr 83:1039–1046PubMed
30.
go back to reference Lopez-Garcia E, van Dam RM, Willett WC et al (2006) Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 113:2045–2053PubMedCrossRef Lopez-Garcia E, van Dam RM, Willett WC et al (2006) Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 113:2045–2053PubMedCrossRef
31.
go back to reference Klag MJ, Wang NY, Meoni LA et al (2002) Coffee intake and risk of hypertension: the Johns Hopkins precursors study. Arch Intern Med 162:657–662PubMedCrossRef Klag MJ, Wang NY, Meoni LA et al (2002) Coffee intake and risk of hypertension: the Johns Hopkins precursors study. Arch Intern Med 162:657–662PubMedCrossRef
32.
go back to reference Hartley TR, Lovallo WR, Whitsett TL (2004) Cardiovascular effects of caffeine in men and women. Am J Cardiol 93:1022–1026PubMedCrossRef Hartley TR, Lovallo WR, Whitsett TL (2004) Cardiovascular effects of caffeine in men and women. Am J Cardiol 93:1022–1026PubMedCrossRef
33.
go back to reference Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC (2005) Habitual caffeine intake and the risk of hypertension in women. JAMA 294:2330–2335PubMedCrossRef Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC (2005) Habitual caffeine intake and the risk of hypertension in women. JAMA 294:2330–2335PubMedCrossRef
34.
go back to reference Weusten-Van der Wouw MP, Katan MB, Viani R et al (1994) Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res 35:721–733PubMed Weusten-Van der Wouw MP, Katan MB, Viani R et al (1994) Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res 35:721–733PubMed
35.
go back to reference Du Y, Melchert HU, Knopf H, Braemer-Hauth M, Gerding B, Pabel E (2005) Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers—results of German National Health Surveys from 1984 to 1999. Eur J Epidemiol 20:311–316PubMedCrossRef Du Y, Melchert HU, Knopf H, Braemer-Hauth M, Gerding B, Pabel E (2005) Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers—results of German National Health Surveys from 1984 to 1999. Eur J Epidemiol 20:311–316PubMedCrossRef
36.
go back to reference Ceriello A, Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816–823PubMedCrossRef Ceriello A, Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816–823PubMedCrossRef
37.
go back to reference Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRef Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820PubMedCrossRef
38.
go back to reference Tesfamariam B (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16:383–391PubMedCrossRef Tesfamariam B (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16:383–391PubMedCrossRef
39.
go back to reference Pieper GM, Gross GJ (1998) Oxygen free radicals abolish endothelium dependent relaxation in diabetic art aorta. Am J Physiol 255:H825–H833 Pieper GM, Gross GJ (1998) Oxygen free radicals abolish endothelium dependent relaxation in diabetic art aorta. Am J Physiol 255:H825–H833
40.
go back to reference Rösen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO–MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189–212PubMedCrossRef Rösen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO–MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189–212PubMedCrossRef
41.
go back to reference Hirsh IB, Brownlee M (2005) Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complicat 19:178–181CrossRef Hirsh IB, Brownlee M (2005) Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complicat 19:178–181CrossRef
42.
go back to reference Graier WF, Simecek S, Kukovetz WR, Kostner GM (1996) High glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45:1386–1395PubMed Graier WF, Simecek S, Kukovetz WR, Kostner GM (1996) High glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45:1386–1395PubMed
43.
go back to reference Diedrich D, Skopec J, Diedrich A, Dai FX (1994) Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266:H1153–H1161 Diedrich D, Skopec J, Diedrich A, Dai FX (1994) Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266:H1153–H1161
44.
go back to reference Tesfamariam B, Brown ML, Deykin D, Cohen RA (1990) Elevated glucose promotes generation of endothelium-dependent vasoconstrictive prostanoids in rabbit aorta. J Clin Invest 85:929–932PubMedCrossRef Tesfamariam B, Brown ML, Deykin D, Cohen RA (1990) Elevated glucose promotes generation of endothelium-dependent vasoconstrictive prostanoids in rabbit aorta. J Clin Invest 85:929–932PubMedCrossRef
45.
go back to reference Qiao Q, Pyörälä K, Pyörälä M et al (2002) Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 23:1267–1275PubMedCrossRef Qiao Q, Pyörälä K, Pyörälä M et al (2002) Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 23:1267–1275PubMedCrossRef
46.
go back to reference The DECODE Study Group (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly diagnosed diabetes. Diabetologia 46:608–617CrossRef The DECODE Study Group (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly diagnosed diabetes. Diabetologia 46:608–617CrossRef
47.
go back to reference Van Dam RM, Dekker JM, Nijpels G, Stehouwer CDA, Bouter LM, Heine RJ (2004) Coffee consumption and incidence of impaired fasting glucose, impaired glucose, and type 2 diabetes: the Hoorn Study. Diabetologia 47:2152–2159PubMedCrossRef Van Dam RM, Dekker JM, Nijpels G, Stehouwer CDA, Bouter LM, Heine RJ (2004) Coffee consumption and incidence of impaired fasting glucose, impaired glucose, and type 2 diabetes: the Hoorn Study. Diabetologia 47:2152–2159PubMedCrossRef
48.
go back to reference Yamaji T, Mizoue T, Tabata S et al (2004) Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia 47:2145–2151PubMedCrossRef Yamaji T, Mizoue T, Tabata S et al (2004) Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia 47:2145–2151PubMedCrossRef
49.
go back to reference Bidel S, Hu G, Sundvall J, Kaprio J, Tuomilehto J (2006) Effects of coffee consumption on glucose tolerance and serum glucose and insulin levels—a cross sectional analysis. Horm Metab Res 38:38–43PubMedCrossRef Bidel S, Hu G, Sundvall J, Kaprio J, Tuomilehto J (2006) Effects of coffee consumption on glucose tolerance and serum glucose and insulin levels—a cross sectional analysis. Horm Metab Res 38:38–43PubMedCrossRef
50.
go back to reference Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K (2001) Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 2. Alpha-glucosidase inhibition by isolated acylated anthocyanins. J Agric Food Chem 49:1952–1956PubMedCrossRef Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K (2001) Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 2. Alpha-glucosidase inhibition by isolated acylated anthocyanins. J Agric Food Chem 49:1952–1956PubMedCrossRef
Metadata
Title
Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes
Authors
S. Bidel
G. Hu
Q. Qiao
P. Jousilahti
R. Antikainen
J. Tuomilehto
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0435-9

Other articles of this Issue 11/2006

Diabetologia 11/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.